Pediatric Oncology
Classification, Epidemiology, Clinical Features, Prognosis
Prof. Imran Iqbal
Fellowship in Pediatric Neurology (Australia)
Prof of Paediatrics (2003-2018)
Prof of Pediatrics Emeritus, CHICH
Prof of Pediatrics, CIMS
Multan, Pakistan
It contains estimated 200 Billion Stars, the sun lies roughly 27,000 light-years
from the centre of the galaxy. And there are estimated minimum
100 Billion Galaxies in the Universe.
(God speaking to Prophet Muhammad (PBUH)
And (remember) Ayub (Job), when he called his Lord saying
“I have been afflicted by distress (disease), and
You are the most merciful of all those who have mercy”
The Holy Quran; surah Al-Anbiya 21:83
In the name of Our Creator Allah, the most Gracious, the most Merciful
Pediatric Oncology - Epidemiology
• Malignancies are one of the leading causes of death in
children under 15 years of age
• It is estimated that approximately 7500- 8000 children less
than 18 years get cancer, every year in Pakistan.
Pediatric Oncology – Types of Malignancies
Pakistan Data
Disease Percentage
Leukemia 35
Lymphoma 20
Bone Tumor 08
Soft Tissue Sarcoma 07
Brain Tumor 07
Retinoblastoma 06
Neuroblastoma 04
Wilms Tumor 04
Germ Cell Tumor 03
Others 06
Pediatric Oncology
Lymphoma in Children
Classification, Epidemiology, Clinical Features,
Diagnosis, Complications, Management
Prof. Imran Iqbal
Fellowship in Pediatric Neurology (Australia)
Prof of Paediatrics (2003-2018)
Prof of Pediatrics Emeritus, CHICH
Prof of Pediatrics, CIMS
Multan, Pakistan
Lymphoma
Definition
• Lymphoma is an uncontrolled malignant proliferation of
Lymphoid cells
• Lymphoid cells are found in primary lymph organs and
secondary lymph organs
• Primary lymph organs – Bone marrow (B - cells) and Thymus
(T - cells)
• Secondary lymph organs – Lymph nodes, Spleen, and
Mucosa-associated lymphoid tissue (MALT).
Lymphoma
Types
• Hodgkin lymphoma – HL (Reed-Sternberg cells)
• Non-Hodgkin lymphoma – NHL
Lymphoma
Epidemiology
• Hodgkin lymphoma – HL
• Common Age = 10 – 20 years
• Slow growing in months to years
• Non-Hodgkin lymphoma – NHL
• Common Age = 5 - 10 years
• Fast growing in weeks to months
Lymphoma
Histology
Hodgkin Lymphoma
Histology
• Hodgkin lymphoma – HL
• Lymphocyte Predominance – 30 %
• Lymphocyte Depletion – 10 %
• Mixed cellularity – 50 %
• Nodular Sclerosis – 10 %
Non - Hodgkin Lymphoma
Histology
• Non - Hodgkin lymphoma – NHL
• Burkitt Lymphoma (B-cell) – 50 %
• Lymphoblastic Lymphoma (T-cell) – 15 %
• Diffuse Large Cell Lymphoma (B-cell) – 30 %
Lymphoma
Clinical Features
Hodgkin Lymphoma
Clinical Features
• Lymph node enlargement –
(Cervical, Axillary, Abdominal)
• Fever
• Weight loss
• Night sweats
• Anemia
• Hepatosplenomegaly
Non-Hodgkin Lymphoma
Clinical Features
• Abdominal mass
• Mediastinal mass
• Jaw swelling
• Fever
• Weight loss
• Anemia
Lymphoma
Differential Diagnosis
Hodgkin Lymphoma
Differential Diagnosis
• Acute lymphadenitis
• Chronic lymphadenitis
• Tuberculosis
Non - Hodgkin Lymphoma
Differential Diagnosis
• Tuberculosis
• Neuroblastoma (abdomen)
• Rhadomyosarcoma
Lymphoma
Investigations
Hodgkin Lymphoma
Investigations
• CBC, ESR, CRP
• LFT, RPM, LDH, Uric acid
• Coagulation profile
• US abdomen
• X-ray Chest
• CT scan Thorax / Abdomen
• Bone Marrow Biopsy
• Lymph Node Biopsy - Histopathology
Non – Hodgkin Lymphoma
Investigations
• CBC, ESR, CRP
• LFT, RPM, LDH, Uric acid
• Coagulation profile
• US abdomen
• X-ray Chest
• CT scan Thorax / Abdomen
• Bone Marrow Biopsy
• Tissue Biopsy - Histopathology
Lymphoma
Management
Lymphoma
Supportive Treatment
• Blood component transfusions (Packed RBCs, Platelets)
• Neutrophil stimulation factors (GM-CSF for neutropenia)
• Antibiotics – for prophylaxis and treatment of infections
• Anti-emetics – for chemotherapy induced emesis
• Tumor Lysis Syndrome – fluids, allopurinol
• Nursing Care – IV sites, mouth, skin
• Nutritional support – High calorie, palatable diet
• Psychosocial support – Patients and families
Hodgkin Lymphoma
Management
• Management is done in specific centres
• Multi-agent cytotoxic chemotherapy is given in the form of
monthly cycles
• ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)
• COPP (Cyclophosphamide, Vincristine, Procarbazine,
Prednisolone)
• Total duration is 6 – 12 months
Non – Hodgkin Lymphoma
Management
• Management is done in specific centres
• Multi-agent cytotoxic Chemotherapy is given
• Cyclophosphamide, Vincristine, Daunorubicin, Asparaginase,
Methotrexate, Prednisolone are commonly used
• Dissemination of Lymphoblastic cells to blood (Acute
Lymphoblastic Leukemia) can occur
• Prognosis depends on histology and stsging of disease

Lymphoma in children 2021

  • 1.
    Pediatric Oncology Classification, Epidemiology,Clinical Features, Prognosis Prof. Imran Iqbal Fellowship in Pediatric Neurology (Australia) Prof of Paediatrics (2003-2018) Prof of Pediatrics Emeritus, CHICH Prof of Pediatrics, CIMS Multan, Pakistan
  • 2.
    It contains estimated200 Billion Stars, the sun lies roughly 27,000 light-years from the centre of the galaxy. And there are estimated minimum 100 Billion Galaxies in the Universe.
  • 3.
    (God speaking toProphet Muhammad (PBUH) And (remember) Ayub (Job), when he called his Lord saying “I have been afflicted by distress (disease), and You are the most merciful of all those who have mercy” The Holy Quran; surah Al-Anbiya 21:83 In the name of Our Creator Allah, the most Gracious, the most Merciful
  • 4.
    Pediatric Oncology -Epidemiology • Malignancies are one of the leading causes of death in children under 15 years of age • It is estimated that approximately 7500- 8000 children less than 18 years get cancer, every year in Pakistan.
  • 5.
    Pediatric Oncology –Types of Malignancies Pakistan Data Disease Percentage Leukemia 35 Lymphoma 20 Bone Tumor 08 Soft Tissue Sarcoma 07 Brain Tumor 07 Retinoblastoma 06 Neuroblastoma 04 Wilms Tumor 04 Germ Cell Tumor 03 Others 06
  • 7.
    Pediatric Oncology Lymphoma inChildren Classification, Epidemiology, Clinical Features, Diagnosis, Complications, Management Prof. Imran Iqbal Fellowship in Pediatric Neurology (Australia) Prof of Paediatrics (2003-2018) Prof of Pediatrics Emeritus, CHICH Prof of Pediatrics, CIMS Multan, Pakistan
  • 8.
    Lymphoma Definition • Lymphoma isan uncontrolled malignant proliferation of Lymphoid cells • Lymphoid cells are found in primary lymph organs and secondary lymph organs • Primary lymph organs – Bone marrow (B - cells) and Thymus (T - cells) • Secondary lymph organs – Lymph nodes, Spleen, and Mucosa-associated lymphoid tissue (MALT).
  • 9.
    Lymphoma Types • Hodgkin lymphoma– HL (Reed-Sternberg cells) • Non-Hodgkin lymphoma – NHL
  • 10.
    Lymphoma Epidemiology • Hodgkin lymphoma– HL • Common Age = 10 – 20 years • Slow growing in months to years • Non-Hodgkin lymphoma – NHL • Common Age = 5 - 10 years • Fast growing in weeks to months
  • 11.
  • 12.
    Hodgkin Lymphoma Histology • Hodgkinlymphoma – HL • Lymphocyte Predominance – 30 % • Lymphocyte Depletion – 10 % • Mixed cellularity – 50 % • Nodular Sclerosis – 10 %
  • 13.
    Non - HodgkinLymphoma Histology • Non - Hodgkin lymphoma – NHL • Burkitt Lymphoma (B-cell) – 50 % • Lymphoblastic Lymphoma (T-cell) – 15 % • Diffuse Large Cell Lymphoma (B-cell) – 30 %
  • 14.
  • 15.
    Hodgkin Lymphoma Clinical Features •Lymph node enlargement – (Cervical, Axillary, Abdominal) • Fever • Weight loss • Night sweats • Anemia • Hepatosplenomegaly
  • 16.
    Non-Hodgkin Lymphoma Clinical Features •Abdominal mass • Mediastinal mass • Jaw swelling • Fever • Weight loss • Anemia
  • 17.
  • 18.
    Hodgkin Lymphoma Differential Diagnosis •Acute lymphadenitis • Chronic lymphadenitis • Tuberculosis
  • 19.
    Non - HodgkinLymphoma Differential Diagnosis • Tuberculosis • Neuroblastoma (abdomen) • Rhadomyosarcoma
  • 20.
  • 21.
    Hodgkin Lymphoma Investigations • CBC,ESR, CRP • LFT, RPM, LDH, Uric acid • Coagulation profile • US abdomen • X-ray Chest • CT scan Thorax / Abdomen • Bone Marrow Biopsy • Lymph Node Biopsy - Histopathology
  • 22.
    Non – HodgkinLymphoma Investigations • CBC, ESR, CRP • LFT, RPM, LDH, Uric acid • Coagulation profile • US abdomen • X-ray Chest • CT scan Thorax / Abdomen • Bone Marrow Biopsy • Tissue Biopsy - Histopathology
  • 23.
  • 24.
    Lymphoma Supportive Treatment • Bloodcomponent transfusions (Packed RBCs, Platelets) • Neutrophil stimulation factors (GM-CSF for neutropenia) • Antibiotics – for prophylaxis and treatment of infections • Anti-emetics – for chemotherapy induced emesis • Tumor Lysis Syndrome – fluids, allopurinol • Nursing Care – IV sites, mouth, skin • Nutritional support – High calorie, palatable diet • Psychosocial support – Patients and families
  • 25.
    Hodgkin Lymphoma Management • Managementis done in specific centres • Multi-agent cytotoxic chemotherapy is given in the form of monthly cycles • ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) • COPP (Cyclophosphamide, Vincristine, Procarbazine, Prednisolone) • Total duration is 6 – 12 months
  • 26.
    Non – HodgkinLymphoma Management • Management is done in specific centres • Multi-agent cytotoxic Chemotherapy is given • Cyclophosphamide, Vincristine, Daunorubicin, Asparaginase, Methotrexate, Prednisolone are commonly used • Dissemination of Lymphoblastic cells to blood (Acute Lymphoblastic Leukemia) can occur • Prognosis depends on histology and stsging of disease